Shiwen Guo

Shiwen Guo

Auto-generated profile, based on publicly available information

Shiwen Guo

Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiaotong University, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
XLXinwen Lv
Xinwen Lv
MWMeihua Wang
Meihua Wang
JQJingli Qiang
Jingli Qiang
SGShiwen Guo
Shiwen Guo

6 November 2017 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
RFRui Fu
Rui Fu
YDYan Ding
Yan Ding
JLJie Luo
Jie Luo
LYLi Yu
Li Yu
CLCheng Lin Li
Cheng Lin Li
SGShi Wen Guo
Shi Wen Guo
DNA methylation and demethylation play a critical role in the regulation of the molecular pathogenesis of gliomas. Tet methylcytosine dioxygenase 1 (TET1) catalyses the sequential oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine, (5hmC) leading to eventual DNA demethylation. It has been reported that TET1 is a tumour suppressor in several cancers. However, whether TET1 plays a role in glioma development is largely unclear. Different glioma specimens and corresponding normal controls were collected to analyse the expression of TET1. At the same time, TET1 of glioma U251 cells was knocked down or overexpressed to observe its effect on glioma cell proliferation and invasion as well as autophagy level. Here, we reported that the expression of TET1 in glioma tissue was significantly lower than the corresponding non-tumour normal tissues, and the concentration of TET1 is negatively correlated with the glioma WHO classification. When TET1 gene in glioma U251 cells was knocked down by CRISPR/Caspase-9 system, the proliferation and invasive ability of U251 increased remarkably. But when TET1 was overexpressed in U251 cells, the proliferation and invasion were impaired. Following the down-expression of TET1, the level of autophagy in U251 cells decreased accordingly.However, when TET1 was overexpressed in U251 cells, the level of autophagy incraesed. Furthermore, bafilomycin A1 (Baf-A1) but not 3-methyladenine (3-MA) could decrease the autophagy level of TET1−/− U251 cells as the wild-type controls. It suggests that the tumour suppressor effect of TET1 seems to be mediated by regulating the level of autophagy, and the regulation of TET1 on autophagy is at an early stage.

13 February 2020 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
SJShangguan Jian
Shangguan Jian
LCLiang Chen
Liang Chen
LMLian Minxue
Lian Minxue
CHChe Hongmin
Che Hongmin
TRTang Ronghua
Tang Ronghua
GSGuo Shiwen
Guo Shiwen
Glioma is the most common primary malignancy of the central nervous system and is associated with high mortality rates. Despite the available treatment options including surgery, radiotherapy and chemotherapy, the median patient survival rate is low. Therefore, the development of novel anticancer agents for the treatment of glioma is urgently required. Tanshinone I (TS I) is a tanshinone compound that is isolated from Danshen. Accumulating evidence indicates that TS I exhibits antiproliferative activity in a variety of cancer types. However, the role of TS I and its mechanism of action in human glioma remain to be elucidated. In the present study, the anticancer potential of TS I against human glioma U87 MG cells was investigated. The results indicated that TS I exerted a potential cytotoxic effect on human glioma U87 MG cells. TS I was found to induce cell proliferation, inhibition, cell cycle arrest, apoptosis and autophagy in U87 MG cells. Mechanistic experiments indicated that TS I activated endoplasmic reticulum (ER) stress and inhibited AKT signaling and apoptosis in human glioma U87 MG cells. Furthermore, the present study demonstrated that TS I induced protective autophagy in U87 MG cells. Additionally, ER stress and AKT signal‑mediated apoptosis and protective autophagy were found to be induced by TS I via intracellular reactive oxygen species accumulation. The results of the present study demonstrated that TS I may be a potential anticancer drug candidate that may be of value in the treatment of human glioma.

13 June 2018 in NeuroReport
Verified
Journal Article
Closed access
RFRui Fu
Rui Fu
YDYan Ding
Yan Ding
JLJie Luo
Jie Luo
KHKuan Ming Huang
Kuan Ming Huang
XTXiang Jun Tang
Xiang Jun Tang
SGShi Wen Guo
Shi Wen Guo
Ten-eleven translocation 1 catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), which plays an important role in epigenetics and is related to the malignant biological behavior of tumors. However, its regulatory role in glioma remains unclear. In this study, the levels of 5mC and 5hmC were detected using immunohistochemistry, dot-blot, hMeDIP-chip, and western blot in glioma tissues and normal brain tissues, whereas 5hmC differentially enriched genes were determined and further validated. The level of 5hmC in gliomas was decreased, whereas 5mC was increased. 5hmC highly enriched 10 functional protein-coding genes and 10 signaling pathways were identified using hMeGIP-chip in glioma tissues. Two autophagy-related genes, ATG13 and DNA damage-regulated autophagy modulator protein 1, with low enrichment of 5hmC in glioma tissues were verified in the promoter region, and hMeGIP-PCR further confirmed this result in U251 cells. Immunohistochemistry further confirmed that autophagy level in glioma tissues was lower than that of normal controls, and negatively correlated with WHO grade. This study indicates that ten-eleven translocation 1 may be involved in the development and progression of glioma through demethylation regulating a variety of cellular functions and signaling pathways, and autophagy is one of the regulatory mechanisms.

28 December 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ZBZhijun Bao
Zhijun Bao
LCLihua Chen
Lihua Chen
SGShiwen Guo
Shiwen Guo

24 February 2011 in Cancer Science
Verified
Journal Article
Closed access
PDF file
SGShi‐Wen Guo
Shi‐Wen Guo
HCHong‐Min Che
Hong‐Min Che
WLWen‐Zhi Li
Wen‐Zhi Li